Chlorhexidine Diacetate
CAS 56-95-1
Chlorhexidine Diacetate (CAS 56-95-1) is a Phase 3 pharmaceutical compound with 2 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Clinical Development Phase
Highest clinical development phase rendered from the matched compound identifier rows.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | Potency | 39054.93636363636 nM | 11 | - |
| - | MIC | 1.65 ug.mL-1 | 4 | - |
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| CHLORHEXIDINE ACETATE | 2359 | SU | MTHSPL |
| CHLORHEXIDINE DIACETATE | 133054 | SU | MTHSPL |
| chlorhexidine diacetate | 133054 | PIN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Chlorhexidine Diacetate used for in pharmaceutical contexts?
Chlorhexidine Diacetate (CAS 56-95-1) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Chlorhexidine Diacetate?
No adverse-event association or SIDER side-effect rows are rendered for Chlorhexidine Diacetate in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Chlorhexidine Diacetate also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for CHLORHEXIDINE DIACETATE with EU status "restricted".
What clinical phase is Chlorhexidine Diacetate in?
Chlorhexidine Diacetate is rendered with ChEMBL max phase 3.